Get Connected:

 
Hybrid Closed-Loop System Favorable for Type 1 Diabetes
Closed-loop systems help diabetes patients achieve blood glucose control, according to a presentation at the American Diabetes Association’s 77th Scientific Sessions.
Transition Programs Beneficial for Youth with Diabetes Moving to Adult Care
Transition care may improve diabetes outcomes, according to a study presented at the American Diabetes Association’s 77th Scientific Sessions.
Continuous Glucose Monitoring Beneficial for Patients with Diabetes
American Diabetes Association’s 77th Scientific Sessions highlight benefits of glucose monitoring.
Metformin Observed to Reduce Heart Disease Risk in Type 1 Diabetes
REMOVAL trial results presented at the American Diabetes Association’s 77th Scientific Sessions.
PCSK9 Inhibitors Reduce Cardiovascular Risks in Type 2 Diabetes

Results of the ODYSSEY study presented at the American Diabetes Association’s 77th Scientific Sessions.

Findings from inTandem1 and inTandem2 Featured at ADA Scientific Sessions
Sotagliflozin effective in treating patients with type 1 diabetes.
Soliqua Shows Promise Lowering Hemoglobin A1C Levels in Type 2 Diabetes
Findings presented at ADA conference highlight effiacy of insulin glargine/lixisenatide combination.
Study Shows Switching to Toujeo Lowers Risk of Hypoglycemia in Seniors With Diabetes
Patients who switched to insulin glargine were 57% less likely to experience hypoglycemia.
Texting System Helps Teens With Diabetes Improve Glycemic Control
Two-way text messaging system either maintained or improved A1C levels for teens with type 1 diabetes.
Eicosapentaenoic Acid May be Beneficial for Diabetes Patients
Icosapeny ethyl reduced triglyceride levels for patients with diabetes, according to a session presented at the ADA 77th Annual Scientific Sessions.
Risk of Type 2 Diabetes Skyrockets in Severely Obese Children
Severe obesity in childhood leads to 12 times greater risk of developing type 2 diabetes (T2D) by age 20, according to study presented at ADA’s 77th Scientific Session.
Overweight Male Children Can Still Avoid Type 2 Diabetes in Adulthood

Study presented at ADA’s 77th Scientific Sessions finds boys who are overweight during childhood can normalize their weight as young adults without an elevated diabetes risk.

Inhibiting PCSK9 in Dyslipidemia Patients with Diabetes
Symposium on PCSK9 inhibitors in treatment of type 1 diabetes highlighted at 77th Scientific Sessions of the ADA. 
DEVOTE Trial Shows Cardiovascular Safety Data for Insulin Degludec
Tresiba found to offer patients with type 2 diabetes (T2D) a lower risk of severe hypoglycemia.
Technology Platform May Improve Diabetes Management
BioChaperone platform could increase the efficacy and safety of diabetes drugs.
Diabetes Complication Research Honored by ADA
Research of macrovascular complications in diabetes honored at American Diabetes Association’s 77th Scientific Sessions.
ADA Honors Gestational Diabetes Research
Researcher awarded for improving the understanding of diabetes during pregnancy.
ADA Honors Contributions to Behavioral Care for Diabetes

Type 1 diabetes researcher awarded at American Diabetes Association’s 77th Scientific Sessions.

Diabetes Drugs in Spotlight at ADA Annual Meeting
Manufacturers to present data from studies of diabetes drugs at American Diabetes Association 77th Scientific Sessions.
American Diabetes Association Joins With Walmart for 'Wellness Day'
One in 11 Americans has diabetes today, and 86 million more – about one in three – are at risk for developing type 2 diabetes.
American Diabetes Association Meeting Kicks Off Today
The 77th Annual Scientific Sessions of the American Diabetes Association is being held in San Diego June 9 through June 13